The largest database of trusted experimental protocols

Astrocyte growth media

Manufactured by Lonza
Sourced in Switzerland

Astrocyte Growth Media is a specialized cell culture medium designed to support the growth and maintenance of astrocytes, a type of glial cell found in the central nervous system. The media is formulated to provide the necessary nutrients and growth factors required for optimal astrocyte proliferation and differentiation, enabling researchers to study these important cells in vitro.

Automatically generated - may contain errors

10 protocols using astrocyte growth media

1

Cytokine-Induced Astrocyte Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultured primary human cortical astrocytes (HA1800) were purchased from ScienCell (Carlsbad, CA) and treated with cytokines: IL-1α, TNF- α, and C1q for 24 hrs21 (link). Astrocytes were treated with LXB4 (Cayman Chemicals, Ann Arbor, MI) (1μM) or vehicle for 20 mins before adding cytokines. After 24 hrs, the cells were collected in Trizol (Invitrogen, Waltham, MA) for RNA isolation or ice-cold methanol for lipidomic analysis. For primary retinal astrocytes, four mice retinas were pooled and digested using papain (Worthington, Lakewood, NJ) and plated on Poly-D-Lysine coated flasks with Astrocyte Growth Media (Lonza, Basel, Switzerland), changing the media every 3 days.
+ Open protocol
+ Expand
2

Glioma Cell Lines and Inhibitor Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human glioma cell lines T98G and U87 were purchased from the ATCC (American Type Culture Collection) and were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% of heat-inactivated fetal bovine serum (FBS) and cultured at 37°C, 5% carbon dioxide in a humidified chamber. NHAs were purchased from Lonza (Lonza, Walkersville, MD) and maintained in Astrocyte Growth Media (Lonza) con-taining 2.5% FBS, 0.1% ascorbic acid, 0.5% recombinant human epidermal growth factor, 0.1% GA-1000, 0.25% insulin, and 1% L-glutamine (Lonza). LIMK inhibitor was purchased from SYNKINASE (SYN-1024 BMS-5) and Cucurbitacin I was purchased from Sigma-Aldrich (C-4493). Both drugs were dissolved in DMSO making a master stock of 1 mM and used at doses and times points listed in the Results section.
+ Open protocol
+ Expand
3

Astrocyte Response to Inflammatory Stimuli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultured primary human cortical astrocytes (HA1800) were purchased from ScienCell (Carlsbad, CA) and treated with the cytokines: IL-1α, TNF- α, and C1q for 24 h [20 ]. Astrocytes were treated with LXB4 (Cayman Chemicals, Ann Arbor, MI) (1 µM) or vehicle for 20 min before adding cytokines. After 24 h, the cells were collected in TRIzol (Invitrogen, Waltham, MA) for RNA isolation or ice-cold methanol for lipidomic analysis. For primary retinal astrocytes and optic nerve astrocytes, four mouse retinas were pooled and digested using papain (Worthington, Lakewood, NJ) and plated on poly-D-lysine coated flasks with astrocyte growth media (Lonza, Basel, Switzerland), changing the media every 3 days. Over 95% of the cultured cells were identified as astrocytes through immunofluorescence staining for GFAP and vimentin and were negative for RGCs, microglia, and oligodendrocyte markers.
+ Open protocol
+ Expand
4

Establishment of Primary Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated human umbilical vein endothelial cells (HUVECs) were provided kindly by Dr. Andrew Putnam (University of Michigan) and propagated in fully supplemented EGM-2 growth medium (Lonza). Human hepatic sinusoidal endothelial cells (HHSEC, ScienCell#5000) were cultured in EGM-2 (Lonza). Human brain vascular adventitial fibroblasts (HBVAFs, #1110) and human lung fibroblast (LFs,#3300) were obtained commercially (ScienCell) and propagated in high-glucose DMEM supplemented with 10% fetal bovine serum (FBS, ThermoFisher). Human astrocytes (ScienCell#1800) were cultured in Astrocyte Growth Media (Lonza). Bone marrow-derived human mesenchymal stem cells (MSCs, ScienCell#7500) were cultured and propagated in low-glucose DMEM supplemented with 10% FBS. All primary human cells were used in experiments from passages eight to ten.
T4-2 cells were kind gift of Dr. Mina Bissell at Lawrence Berkeley National Laboratory, University of California, Berkeley, and grown as described previously62 . MDA-MB-231 were purchased from ATCC (#HTB26) and its brain-metastatic derivative line MDA-MB-231-BR7 was generously provided by Dr. Patricia Steeg (NCI) 64 . Both MDA-MB-231 and MDA-MB-231-BR7 cells were grown in high-glucose DMEM supplemented with 10% FBS. Triple-negative murine mammary tumor line E0771 (Ch3 Biosystems#94A001) were grown in high-glucose DMEM supplemented with 10% FBS.
+ Open protocol
+ Expand
5

Culturing Glioblastoma and Astrocyte Cells in Hydrogels

Check if the same lab product or an alternative is used in the 5 most similar protocols
U-87 MG primary human glioblastoma cells (ATCC), D1TNC1 rat astrocyte cells (ATCC), and C6 rat glioblastoma cells (ATCC) were all cultured in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (PS). Normal Human Astrocyte (NHA) cells (Lonza) were cultured in Astrocyte Growth Media (Lonza). PC12 undifferentiated rat neurons (ATCC) were cultured in DMEM containing 5% horse serum, 5% calf serum and 1% PS. DBTRG human glioblastoma cells (ATCC) were culture in RPMI medium containing 10% FBS, 2 mM L-glutamine, 1% PS and 0.1 mM non-essential amino acids. All cells were grown in culture at 37 °C in 5% CO2 in a humidified incubator. Cells were seeded in hydrogels at a density of 1 × 106 cells/mL. The hydrogels were submerged in appropriate growth media for the cell type at 37 °C in 5% CO2 in a humidified incubator and cell viability was maintained within hydrogels for up to 7 days (Fig. 2a).
+ Open protocol
+ Expand
6

Culturing Normal Human Astrocytes and Glioblastoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human astrocytes (NHAs) were obtained from Lonza (Basel, Switzerland) and cultured in astrocyte growth media (Lonza) containing 3% fetal bovine serum (FBS), 4.5% glucose and reagents from BulletKits (Lonza) in a humidified incubator at 37°C and 5% CO2. Human GBM cell lines U87-MG, U251 and HEK-293T were purchased from Chinese Academy of Sciences Cell Bank (Shanghai, People’s Republic of China), and were cultured in DMEM (Hyclone, Logan, UT, USA) supplemented with 100 units of penicillin/mL, 100 ng of streptomycin/mL as well as 10% FBS. All the cells were maintained at 37°C in a humidified atmosphere with 5% CO2.
+ Open protocol
+ Expand
7

Astrocyte Differentiation from Neural Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Astrocytes were differentiated from the NPCs following a protocol detailed elsewhere (Freitas, et al, 2016 Neuron - in press). Briefly, a confluent 100 mm diameter NPC plate was scraped forming neurospheres in a six-well plate by keeping at constant shaking (95 rpm). The media was changed on the day after cells were suspended once the neurospheres were well formed using the NPC media containing FGF. After efficient formation of spheres around 48 hrs post scrapping, the rock inhibitor was added to a final concentration of 5 µM for 48 hrs concomitant with the removal of FGF from the media in the next media change. Cells were kept in constant shaking with neuronal inducing media for a week. Next, the astrocyte growth media (Lonza, Allendale, NJ) was added to the spheres for two weeks still under 95 rpm’s. Following two weeks on the astrocyte media, spheres are plated in laminin coated plates and the astrocytes grow out of the sphere spreading on the plate to form a multilayer cell formation. After the first passage, cells surrounding the neurospheres were dissociated enzymatically using accutase (Cellgro) and plated. The neurospheres were removed manually by vacuum suction using a Pasteur pipet and the result was a confluent and homogeneous plate of GFAP and S100β positive astrocytes.
+ Open protocol
+ Expand
8

Establishment of Primary Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated human umbilical vein endothelial cells (HUVECs) were provided kindly by Dr. Andrew Putnam (University of Michigan) and propagated in fully supplemented EGM-2 growth medium (Lonza). Human hepatic sinusoidal endothelial cells (HHSEC, ScienCell#5000) were cultured in EGM-2 (Lonza). Human brain vascular adventitial fibroblasts (HBVAFs, #1110) and human lung fibroblast (LFs,#3300) were obtained commercially (ScienCell) and propagated in high-glucose DMEM supplemented with 10% fetal bovine serum (FBS, ThermoFisher). Human astrocytes (ScienCell#1800) were cultured in Astrocyte Growth Media (Lonza). Bone marrow-derived human mesenchymal stem cells (MSCs, ScienCell#7500) were cultured and propagated in low-glucose DMEM supplemented with 10% FBS. All primary human cells were used in experiments from passages eight to ten.
T4-2 cells were kind gift of Dr. Mina Bissell at Lawrence Berkeley National Laboratory, University of California, Berkeley, and grown as described previously62 . MDA-MB-231 were purchased from ATCC (#HTB26) and its brain-metastatic derivative line MDA-MB-231-BR7 was generously provided by Dr. Patricia Steeg (NCI) 64 . Both MDA-MB-231 and MDA-MB-231-BR7 cells were grown in high-glucose DMEM supplemented with 10% FBS. Triple-negative murine mammary tumor line E0771 (Ch3 Biosystems#94A001) were grown in high-glucose DMEM supplemented with 10% FBS.
+ Open protocol
+ Expand
9

SIV Infection of Primary Macaque Astrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary macaque astrocytes were purchased from Cambrex and cultured in astrocyte growth media with supplements (Lonza) as described previously41 (link). Twenty-four hours prior to infection, astrocyte medium was changed to DMEM with 10% fetal bovine serum. Cells were infected at moi = 0.05 with SIV/17E-Fr59 (link). At six hours post-infection, cells were washed five times with PBS and re-fed with fresh medium. The next day, cells were treated or not with 100 units/mL of recombinant macaque IFN-beta (PBL Assay Science, Piscataway, NJ). Cells were half re-fed twice weekly with medium containing the cytokine as appropriate. Astrocyte lysates at the specified time points were collected in mirVana lysis buffer and stored at −80 °C until RNA purification.
+ Open protocol
+ Expand
10

Differentiation of Astrocytes from NPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Astrocytes were differentiated from the NPCs following a protocol detailed previously (Yao et al., 2016 (link)). Briefly, a confluent 100 mm diameter NPC plate was scraped forming neurospheres in a six-well plate by keeping at constant shaking (95 rpm). Media was changed on the day after cells were suspended once the neurospheres were well formed using NPC media containing FGF. After efficient formation of spheres around 48 hrs post scrapping, rock inhibitor was added to a final concentration of 5 μM for 48 hrs concomitant with the removal of FGF from the media in the next media change. Cells were kept in constant shaking with neuronal inducing media for a week. Next, astrocyte growth media (Lonza, Allendale, NJ) was added to the spheres for two weeks still under 95 rpm’s. Following two weeks on astrocyte media, spheres were plated in laminin coated plates and the astrocytes grew out of the sphere spreading on the plate to form a monolayer cell formation. After the first passage, cells surrounding the neurospheres were dissociated enzymatically using accutase and plated. The neurospheres were removed manually by vacuum suction using a Pasteur pipet and the result was a confluent and homogeneous plate of GFAP and S100β positive astrocytes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!